Showing results (771-780 of 1,275) with videos related to
Sort By:
Pageof 128
Veterinary and Comparative Oncology|October 31, 2019
Pevonedistat targeted therapy inhibits canine melanoma cell growth through induction of DNA re-replication and senescenceElizabeth A Wood, Zhanping Lu, Shuai Jia, et al.Veterinary and Comparative Oncology|February 16, 2020
Inhibition of copper chaperones sensitizes human and canine osteosarcoma cells to carboplatin chemotherapyJordon M Inkol, Andrew C Poon, Anthony J MutsaersVeterinary and Comparative Oncology|February 12, 2020
Refining the "double two-thirds" rule: Genotype-based breed grouping and clinical presentation help predict the diagnosis of canine splenic mass lesions in 288 dogsOwen Davies, Angela J TaylorVeterinary and Comparative Oncology|January 23, 2019
Evaluation of a multi-agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non-Hodgkin high-grade lymphomas: a single centre's experienceKatherine Smallwood, Jean-Benoit Tanis, Iain A Grant, et al.Veterinary and Comparative Oncology|February 14, 2019
Oncolytic activity of canine distemper virus in canine mammary tubular adenocarcinoma cellsPeiran Li, Jigui Wang, Gaoxiang Chen, et al.Veterinary and Comparative Oncology|September 20, 2020
The feasibility and utility of optical coherence tomography directed histopathology for surgical margin assessment of canine mast cell tumoursJosephine A Dornbusch, Christina Cocca, Ryan Jennings, et al.Veterinary and Comparative Oncology|January 27, 2019
Canine CD4+ T-cell lymphoma identified by flow cytometry exhibits a consistent histomorphology and gene expression profileLauren J Harris, Kelly L Hughes, E J Ehrhart, et al.Veterinary and Comparative Oncology|November 7, 2009
Treatment of feline mammary tumours using chemotherapy, surgery and a COX-2 inhibitor drug (meloxicam): a retrospective study of 23 cases (2002-2007)*J F Borrego, J C Cartagena, J EngelVeterinary and Comparative Oncology|November 7, 2009
Effect of recombinant feline interferon-omega alone and in combination with chemotherapeutic agents on putative tumour-initiating cells and daughter cells derived from canine and feline mammary tumoursC Penzo, M Ross, R Muirhead, et al.Veterinary and Comparative Oncology|October 17, 2022
Molecular phenotyping of malignant canine mammary tumours: Detection of high-risk group and its relationship with clinicomolecular characteristicsMohamad Zamani-Ahmadmahmudi, Maziar Jajarmi, Saeedeh TalebipourPageof 128